ScholarIQanswers from OpenAlex

Doxycycline sclerodesis as a treatment option for persistent Morel-Lavallée lesions

PaperCitations, authors & open-access status

Doxycycline sclerodesis as a treatment option for persistent Morel-Lavallée lesions is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Doxycycline sclerodesis as a treatment option for persistent Morel-Lavallée lesions have?

ScholarIQcitation count

Doxycycline sclerodesis as a treatment option for persistent Morel-Lavallée lesions has 115 citations in the OpenAlex counts ScholarIQ stores.

When was Doxycycline sclerodesis as a treatment option for persistent Morel-Lavallée lesions published?

ScholarIQyear

Doxycycline sclerodesis as a treatment option for persistent Morel-Lavallée lesions has 2011 year in the ScholarIQ index.

What is the open-access status of Doxycycline sclerodesis as a treatment option for persistent Morel-Lavallée lesions?

ScholarIQoa status

Doxycycline sclerodesis as a treatment option for persistent Morel-Lavallée lesions has closed oa status in the ScholarIQ index.

What is the DOI of Doxycycline sclerodesis as a treatment option for persistent Morel-Lavallée lesions?

ScholarIQdoi

The DOI for Doxycycline sclerodesis as a treatment option for persistent Morel-Lavallée lesions is on the source record.

What is the PMID of Doxycycline sclerodesis as a treatment option for persistent Morel-Lavallée lesions?

ScholarIQpmid

The PMID for Doxycycline sclerodesis as a treatment option for persistent Morel-Lavallée lesions is on the source record.

What is the OpenAlex record for Doxycycline sclerodesis as a treatment option for persistent Morel-Lavallée lesions?

ScholarIQopenalex

The OpenAlex for Doxycycline sclerodesis as a treatment option for persistent Morel-Lavallée lesions is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial